ERIN ACKERMAN: Open Payments
NPI 1588211643 · HAMILTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 29 payments from 9 companies in 2025. Trend: 2023 $711 · 2024 $644 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Lundbeck LLC | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Alkermes, Inc. | 4 | $61 |
| Braeburn Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| Indivior Inc. | 1 | $19 |
Products named: INGREZZA, Auvelity, INVEGA SUSTENNA, REXULTI, ARISTADA, AUSTEDO XR, BRIXADI, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
